Literature DB >> 12899134

A case of hemiparesis associated with cranial nerve lesions due to intravascular lymphomatosis(2003:4b).

Y De Bruecker1, P Demaerel, G Wilms, R Sciot, F Ballaux, W Robberecht.   

Abstract

Intravascular lymphomatosis is a rare variant of non-Hodgkin's lymphoma with an unusual predilection for the central nervous system. Most cases are not diagnosed until postmortem because of variable clinical presentation and non-specific laboratory findings. We studied a 41-year-old lady who presented with progressive neurological symptoms. MR showed multifocal grey and white matter lesions. Brain biopsy showed an intravascular lymphoma of the B-cell lineage. This report illustrates the ischaemic origin of the radiological lesions, as they are all hyperintense on the diffusion-weighted images. This has, to our knowledge, never been published before. MR did not show any enhancement after intravenous Gadolinium-DTPA (parenchymal or meningeal)which is a very uncommon finding in this entity. Intravascular lymphomatosis should be taken into account in the differential diagnosis of repeated cerebral ischemia of unclear aetiology.

Entities:  

Mesh:

Year:  2003        PMID: 12899134     DOI: 10.1007/s00330-003-1961-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  3 in total

1.  Intravascular lymphoma: magnetic resonance imaging correlates of disease dynamics within the central nervous system.

Authors:  J M Baehring; C Henchcliffe; C J Ledezma; R Fulbright; F H Hochberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

2.  Unusual Magnetic Resonance Imaging and Catheter Angiographic Signs of Intravascular Lymphoma.

Authors:  A H Y Chiu; J Chan; L K Kho; C C Phatouros
Journal:  Clin Neuroradiol       Date:  2014-12-17       Impact factor: 3.649

3.  Construction of a Health Management Model for Early Identification of Ischaemic Stroke in Cloud Computing.

Authors:  Yuying Yang; Qing Chang; Jing Chen; Xiangkun Zhou; Qian Xue; Aixia Song
Journal:  J Healthc Eng       Date:  2022-03-22       Impact factor: 2.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.